关注
Maire F. Osborn
Maire F. Osborn
RNA Therapeutics Institute | Univ. of Massachusetts Medical School
在 umassmed.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Diverse lipid conjugates for functional extra-hepatic siRNA delivery in vivo
A Biscans, A Coles, R Haraszti, D Echeverria, M Hassler, M Osborn, ...
Nucleic acids research 47 (3), 1082-1096, 2019
1572019
Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo
MR Hassler, AA Turanov, JF Alterman, RA Haraszti, AH Coles, MF Osborn, ...
Nucleic acids research 46 (5), 2185-2196, 2018
1562018
Hydrophobically modified siRNAs silence huntingtin mRNA in primary neurons and mouse brain
JF Alterman, LM Hall, AH Coles, MR Hassler, MC Didiot, K Chase, ...
Molecular Therapy-Nucleic Acids 4, 2015
1522015
Improving siRNA Delivery In Vivo Through Lipid Conjugation
MF Osborn, A Khvorova
Nucleic acid therapeutics 28 (3), 128-136, 2018
1192018
Hydrophobicity drives the systemic distribution of lipid-conjugated siRNAs via lipid transport pathways
MF Osborn, AH Coles, A Biscans, RA Haraszti, L Roux, S Davis, S Ly, ...
Nucleic acids research 47 (3), 1070-1081, 2019
1162019
RNA-Pt adducts following cisplatin treatment of Saccharomyces cerevisiae
AA Hostetter, MF Osborn, VJ DeRose
ACS Chemical Biology 7 (1), 218-225, 2011
1162011
Docosahexaenoic acid conjugation enhances distribution and safety of siRNA upon local administration in mouse brain
M Nikan, MF Osborn, AH Coles, BMDC Godinho, LM Hall, RA Haraszti, ...
Molecular Therapy-Nucleic Acids 5, 2016
922016
Excited state proton transfer in the red fluorescent protein mKeima
JN Henderson, MF Osborn, N Koon, R Gepshtein, D Huppert, ...
Journal of the American Chemical Society 131 (37), 13212-13213, 2009
852009
Platinum-RNA modifications following drug treatment in S. cerevisiae identified by click chemistry and enzymatic mapping
MF Osborn, JD White, MM Haley, VJ DeRose
ACS Chemical Biology 9 (10), 2404-2411, 2014
662014
Picazoplatin, an azide-containing platinum (II) derivative for target analysis by click chemistry
JD White, MF Osborn, AD Moghaddam, LE Guzman, MM Haley, ...
Journal of the American Chemical Society 135 (32), 11680-11683, 2013
652013
Guanabenz (Wytensin™) selectively enhances uptake and efficacy of hydrophobically modified siRNAs
MF Osborn, JF Alterman, M Nikan, H Cao, MC Didiot, MR Hassler, ...
Nucleic acids research 43 (18), 8664-8672, 2015
502015
A High-Throughput Method for Direct Detection of Therapeutic Oligonucleotide-Induced Gene Silencing In Vivo
AH Coles, MF Osborn, JF Alterman, AA Turanov, BMDC Godinho, ...
Nucleic Acid Therapeutics, 2015
432015
Novel cluster and monomer-based GalNAc structures induce effective uptake of siRNAs in vitro and in vivo
VK Sharma, MF Osborn, MR Hassler, D Echeverria, S Ly, EA Ulashchik, ...
Bioconjugate chemistry 29 (7), 2478-2488, 2018
382018
Synthesis and Evaluation of Parenchymal Retention and Efficacy of a Metabolically Stable O-Phosphocholine-N-docosahexaenoyl-l-serine siRNA Conjugate in …
M Nikan, MF Osborn, AH Coles, A Biscans, BMDC Godinho, RA Haraszti, ...
Bioconjugate chemistry 28 (6), 1758-1766, 2017
382017
Efficient gene silencing in brain tumors with hydrophobically modified siRNAs
MF Osborn, AH Coles, D Golebiowski, D Echeverria, MP Moazami, ...
Molecular cancer therapeutics 17 (6), 1251-1258, 2018
262018
Binding of kinetically inert metal ions to RNA: the case of platinum (II)
EG Chapman, AA Hostetter, MF Osborn, AL Miller, VJ DeRose
Metal Ions in Life Sciences 9, 347, 2011
242011
Taking charge of siRNA delivery
A Khvorova, MF Osborn, MR Hassler
Nature Biotechnology 32 (12), 1197-1198, 2014
212014
Bioactive conjugates for oligonucleotide delivery
A Khvorova, M Nikan, M Hassler, M Osborn, R Haraszti, A Coles, ...
US Patent 10,633,653, 2020
172020
Bioactive conjugates for oligonucleotide delivery
A Khvorova, M Nikan, M Hassler, M Osborn, R Haraszti, A Coles, ...
US Patent App. 16/812,714, 2020
52020
Compositions and methods for inhibiting gene expression in the central nervous system
BD Brown, M Osborn, W Wang
12022
系统目前无法执行此操作,请稍后再试。
文章 1–20